Sherlock 3CG+™ TCS is indicated to be used in adult and adolescent (greater than 12 through 21) patients with CVADs, such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, and hemodialysis catheters; it is also indicated to be used in children, infants, and neonates with PICCs and centrally inserted central catheters (CICCs).
The Sherlock 3CG+™ TCS is designed to aid in CVAD tip positioning of catheters at least 2 Fr in size through real-time navigation and electrocardiogram (ECG) technology.
The Sherlock 3CG+™ TCS is indicated as an alternative method to chest X-ray and fluoroscopy for CVAD tip placement, eliminating harmful radiation. When compared to traditional PICC placement methods of blind placement and CXR, it has demonstrated proven time and observed cost savings, specifically reduction in time to release PICC patients for IV therapy, malposition rates and chest X-rays.2,3
- Overview
- Integrated Solutions
- Standalone System
- Clinical Study
- Products & Accessories
- EIFU & Resources
Real-time interface
featuring catheter navigation information with Sherlock™ magnet navigation and/or ECG-based navigation.
Catheter tip placement confirmation
with identifiable P-wave via the patient’s cardiac electrical activity. Also includes visual cues for identifying the P-wave and max P-wave.
The through-drape connection
maintains the sterility of the caregiver without compromising the safety or health of patients.
Compatible with Maximal Barrier+ PICC Trays,
which are designed to improve catheter tip tracking accuracy and reliability.
One of the only systems on the market indicated for pediatrics.
Eliminates the need for confirmatory X-ray of PICCs 2 Fr and larger in patients with an identifiable P-wave of approaches from the superior vena cava.
99.1% first-time catheter placement rate
using BD tip confirmation technology on adult patients with an identifiable P-wave when compared to X-ray.5
May save your facility up to 26% in costs
compared to blind placement with X-ray confirmation.2,3
- In each specific age group, the CVAD type and size must be chosen and the CVAD must be used according to the CVAD’s indications and instructions for use.
- Company sponsored study comparing Sherlock 3CG™ TCS on adult patients against historical PICC placement standard of care for blind insertion followed by a chest X-ray (CXR) for tip confirmation. Data on file.
- Reduced cost based on post-hoc exploratory analysis suggesting the costs between the two placement processes are different.
The Sherlock 3CG+™ tip confirmation system (TCS) is indicated for navigation and positioning of central venous access devices (CVADs) of at least 2 Fr in size.
The Sherlock 3CG+™ TCS provides real-time catheter tip location information by using catheter navigation technology along with the patient’s cardiac electrical activity and is indicated for use as an alternative method to chest X-ray Sherlock 3CG+™ TCS and fluoroscopy for CVAD tip placement confirmation of approaches from the superior vena cava.
In adult patients and in adolescents (greater than 12 through 21 years of age), the Sherlock 3CG+™ TCS can be used with CVADs such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports and hemodialysis catheters; in children (greater than 2 to 12 years of age), in infants (greater than 1 month to 2 years of age) and in neonates (from birth to 1 month of age), the Sherlock 3CG+™ TCS can be used with PICCs and with centrally inserted central catheters (CICCs). In each specific age group, the CVAD type and size must be chosen and the CVAD must be used according to the CVAD’s indications and instructions for use.
Limiting but not contraindicated situations for this method are in patients where alterations of cardiac rhythm change the presentation of the P-wave as in atrial fibrillation, atrial flutter, severe tachycardia and pacemaker driven rhythm. In such patients, who are easily identifiable prior to catheter insertion, the use of an additional method is required to confirm catheter tip location.
- In a clinical study, 332 subjects received vascular access devices in the form of PICCs, ports and tunneled catheters of which 114 received PICCs. Placement of PICCs were deemed acceptable in 99.1% (113/114) of the subjects. Pittiruti M (2010) evGuide-Sapiens™ TLS Post-market Clinical Study Report. Catholic University Hospital.
- Pittiruti M, Bertollo D, Briglia E, et al. The Intracavitary ECG Method for Positioning the Tip of Central Venous Catheters: Results of an Italian Multicenter Study. The Journal of Vascular Access. 2012;13(3):357-365. doi:https://doi.org/10.5301/jva.2012.9020
Please consult product labels and inserts for any indications, contraindications, hazards, warnings, cautions and instructions for use.
BD-67856 (11/23)
The Sherlock 3CG+™ TCS simplifies the PICC insertion process by combining CVAD tip placement technology into select Site~Rite™ Ultrasound Systems.
The SiteRite 9™ Ultrasound System is a "one-stop shop" for PICC placement:
- Evaluate and assess patient vasculature
- Select and access the appropriate vessel
- Use the Sherlock 3CG+™ TCS tip tracking technology to locate and navigate the catheter tip to the SVC
- Use the Sherlock 3CG+™ TCS ECG technology to distinguish changes in P-wave amplitude
- Confirm catheter tip placement at the CAJ without the need for a confirmatory chest X-ray
- DICOM or printed documentation
The Sherlock 3CG+™ TCS is available as a separate standalone system for customers not using the Site~Rite 8™ Ultrasound System. This device provides the same great benefits of the integrated system but provides flexibility for use across multiple imaging platforms.
The Sherlock 3CG™ Tip Confirmation System (TCS) Clinical Study
Getting to the heart of the matter…
Using X-ray to confirm PICC tip placement exposes patients to harmful radiation and delays medical therapy. The Sherlock 3CG+™ TCS gets to the heart of this problem by using an adult and pediatric patient's cardiac electrical activity when approaching the superior vena cava to position the tip of the PICC in close proximity to the cavoatrial junction (CAJ). Final tip location is confirmed by the nurse at the bedside and infusion therapy can begin immediately without the need for a confirmatory chest x-ray.
In a clinical study, 99.1% of 114 PICCs were placed at the CAJ or within +/- 1 cm using BD Tip Confirmation Technology.1
1. Pittiruti M (2010) evGuide-Sapiens(TM) TLS Post-market Clinical Study Report. Catholic University Hospital.
